Infertility
Infertility is the failure to conceive after one year of regular unprotected intercourse.
Infertility is a biological condition where a male and a female cannot reproduce. For a healthy organism that has reached sexual maturity, this is usually not the normal state. Medically, the term does not apply to children before puberty or to women after menopause, as these are periods outside the natural, age-related reproductive window.
In humans, infertility is diagnosed when a couple has not become pregnant after at least one year of regular, unprotected intercourse. Many factors can cause infertility, and some can be treated with medical help. According to 1997 estimates, about 5% of heterosexual couples worldwide had an ongoing, unresolved infertility problem. This figure has increased; in 2023, the World Health Organization reported that roughly 17.5% of people experience infertility at some point in their lives, with a point prevalence of 12.6%. A larger group—between 12% and 28% of couples—experience involuntary childlessness for at least one year.
Male factors account for 20–30% of infertility cases, female factors for 20–35%, and combined problems in both partners for 25–40%. In 10–20% of cases, no cause is identified. Among female infertility cases, hormonal issues are most common, including low estrogen, imbalanced gonadotropin-releasing hormone secretion, polycystic ovary syndrome (PCOS), and aging, which often leads to sparse or absent periods before menopause. As women age, the number of ovarian follicles and immature eggs declines, reducing ovarian reserve. Some women experience primary ovarian insufficiency—premature menopause before age 40—which causes infertility. An identifiable cause exists for 85% of infertile couples, leaving 15% as unexplained. Of that 85%, 25% involve disordered ovulation, and 70% of those cases are due to PCOS. Tubal infertility, or structural problems with the fallopian tubes, affects 11–67% of women of childbearing age, with the wide range reflecting different study populations. Endometriosis—where endometrial tissue grows outside the uterus—accounts for 25–40% of female infertility.
During the menstrual cycle, the fertile window—when conception is possible—lasts up to seven days before and during ovulation. Both cycle length and fertile window length vary greatly. Fertility awareness methods track changes in cervical mucus, basal body temperature, or hormone levels to identify this window.
Male infertility most often stems from semen deficiencies, with semen quality serving as a proxy for male fecundity. Other causes include retrograde ejaculation, low testosterone, functional azoospermia (where sperm is not produced or not produced in sufficient numbers), and obstructive azoospermia (where the sperm pathway, such as the vas deferens, is blocked).
Definitions of infertility vary. Demographers often define it as childlessness among women of reproductive age, while epidemiologists focus on “trying for” or “time to” pregnancy in women exposed to conception. Female fertility peaks in young adulthood, declines after age 35, and pregnancy is rare after 50. A woman is most fertile within 24 hours of ovulation. Male fertility peaks in young adulthood and declines after age 40. The required duration of trying to conceive before diagnosis differs across organizations, making prevalence comparisons between countries or over time difficult. A couple that has not conceived after a shorter period is sometimes called subfertile, meaning less fertile than average. Subfertility and infertility are defined similarly and often used interchangeably, though subfertility typically refers to a delay of six to twelve months, while infertility is the inability to conceive naturally within a full year.
The World Health Organization defines infertility as “a disease of the reproductive system defined by the failure to achieve a clinical pregnancy after 12 months or more of regular unprotected sexual intercourse (and there is no other reason, such as breastfeeding or postpartum amenorrhoea).” Primary infertility applies to couples who have never had a child; secondary infertility is the failure to conceive after a previous pregnancy. Infertility may be caused by infection in either partner, but often no obvious cause is found. The WHO also notes that women whose pregnancy ends in miscarriage or stillbirth, without ever having a live birth, are considered to have primary infertility.
In the United States, reproductive endocrinologists commonly use this definition for treatment eligibility: a woman under 35 who has not conceived after 12 months of contraceptive-free intercourse, or a woman over 35 who has not conceived after six months. In the UK, previous NICE guidelines defined infertility as failure to conceive after a specified period.
- field
- Biology, Reproductive Medicine
- male_infertility_cases
- 20–30%
- female_infertility_cases
- 20–35%
- combined_problems
- 25–40%
- unexplained_cases
- 10–20%
Lore & Background
Infertility is defined differently across organizations. The World Health Organization defines it as a disease of the reproductive system characterized by failure to achieve a clinical pregnancy after 12 months or more of regular unprotected sexual intercourse, excluding breastfeeding or postpartum amenorrhea. Primary infertility refers to couples who have never had a child; secondary infertility is failure to conceive following a previous pregnancy. In the United States, a woman under 35 is considered infertile after 12 months of contraceptive-free intercourse, while a woman over 35 is considered infertile after six months. The UK's NICE guidelines recommend clinical assessment after one year for women of reproductive age, with earlier referral for women over 36.
Reader's Guide
Infertility is a significant medical and demographic concern, with prevalence estimates varying due to differing definitions. The most common causes of female infertility are hormonal, including low estrogen, PCOS, and aging, which reduce ovarian reserve. Tubal infertility accounts for 11–67% of female infertility, and endometriosis for 25–40%. Male infertility is most often due to semen deficiencies. About 85% of infertile couples have an identifiable cause, while 15% are unexplained. The condition is not applied to children before puberty or women after menopause, as these are natural states. Fertility awareness methods track cervical mucus, basal body temperature, or hormone measurements to identify the fertile window, which can last up to 7 days before and during ovulation.
Did You Know?
- Female fertility normally peaks in young adulthood and diminishes after age 35, with pregnancy occurring rarely after age 50.
- Male infertility is responsible for 20–30% of infertility cases, while 20–35% are due to female infertility.
Diagnosis and Identification
PMOS is the most common hormonal disorder affecting women of reproductive age, with prevalence estimates ranging from 5% to 18% across populations. The exact root cause remains uncertain, though a clear genetic component exists alongside environmental contributions. Diagnosis requires the presence of at least two of three clinical markers: irregular menstrual cycles, elevated testosterone or its visible manifestations such as excess facial hair, or an abundance of small antral follicles detectable on ultrasound. Notably, despite the older name "polycystic ovary syndrome," women with PMOS are not actually more likely to develop true ovarian cysts than those without the condition. A blood test measuring anti-Müllerian hormone levels can substitute for the ultrasound in diagnostic workups. Additional symptoms that may prompt investigation include heavy periods, persistent acne, difficulty conceiving, and patches of darker, velvety skin known as acanthosis nigricans.
The Symptom Landscape
PMOS presents a remarkably broad spectrum of signs, often emerging at puberty but sometimes concealed if oral contraceptives are initiated early. Menstrual irregularity sits at the center—periods may become infrequent, cease entirely, or arrive as unusually heavy flows. Around 40% of women with PMOS who maintain a regular cycle still experience ovulation-free bleeding. Hirsutism, a pattern of hair growth on the chin, upper lip, chest, upper thighs, and abdomen, affects approximately 60% of those with the condition. Severe acne that outlasts adolescence, androgenic hair loss at the crown of the scalp, persistently oily skin, and dark velvety patches are additional hallmarks. Testosterone levels tend to run about 1.5 times higher than in women without PMOS, and ovaries may appear enlarged with numerous small fluid-filled follicles surrounding eggs. The condition is also one of the leading causes of infertility in women, making reproductive challenges a defining concern for many affected individuals.
Metabolic and Long-Term Health Burden
The metabolic consequences of PMOS extend far beyond reproductive difficulties. Women with the condition face a three- to seven-fold elevated likelihood of developing metabolic disorders compared to those without. Insulin resistance is prevalent even among lean individuals, and when compounded by obesity, it significantly raises the risk of type 2 diabetes and metabolic dysfunction–associated steatotic liver disease, particularly when androgen levels are high. Between 30% and 80% of women with PMOS across different cultures and ancestries are overweight or obese, with marked weight gain occurring between adolescence and adulthood. Cardiovascular risk is also heightened: the incidence of stroke and coronary heart disease is roughly doubled compared to women of similar body mass without PMOS. Metabolic syndrome affects about 40% of those living with the condition. Perhaps most alarmingly, the risk of endometrial cancer is approximately three times higher, linked to infrequent periods and lower levels of sex hormone-binding globulin and progesterone. Sleep apnea is also more common, particularly when obesity is present.
Management and Fertility Pathways
Treatment for PMOS centers on alleviating day-to-day symptoms while mitigating long-term health risks. A healthy lifestyle and weight management form the foundation of general care. Hormonal contraception can regularize menstrual cycles and reduce both acne and unwanted hair growth, while metformin, a standard antidiabetic medication, helps improve insulin sensitivity. For women seeking to conceive, letrozole and other ovulation-induction methods offer a pathway to fertility, addressing PMOS's status as a leading cause of infertility. Ongoing monitoring for cardiometabolic risks is essential throughout life, and pregnancy demands particular vigilance, as PMOS elevates the chances of gestational diabetes, pre-eclampsia, low blood sugar episodes, and the need for neonatal intensive care admission. Miscarriage rates are also higher. Mental health support is increasingly recognized as part of comprehensive care, given the condition's documented associations with depression, anxiety, bipolar disorder, and reduced overall quality of life.
Frequently Asked Questions
Who is Infertility?
Infertility is a reproductive condition in which a sexually mature, otherwise healthy organism is unable to conceive. In human medicine it is formally identified when a couple fails to achieve pregnancy after at least twelve months of regular, unprotected intercourse.
What are Infertility's powers/role?
Infertility acts on both sides of the reproductive equation: male factors drive roughly 20–30% of cases, female factors account for 20–35%, and in 25–40% of situations both partners are contributing simultaneously. Its domain spans Biology and Reproductive Medicine.
How does Infertility's story end?
Infertility is not a fixed, irreversible endpoint; Reproductive Medicine offers a range of diagnostic and therapeutic pathways designed to restore or circumvent the barrier to conception. For many individuals the condition is a chapter rather than a final verdict.
More in Medical Conditions 1-15
Spotted an error? Know more?
This is a living reference — every entry is fact-audited, and reader corrections feed straight into our audit queue. Suggest an edit · See this site's audit record